Genome-wide phage susceptibility analysis in Acinetobacter baumannii reveals capsule modulation strategies that determine phage infectivity
PLOS Pathogens · 08.06.2023 · 19 (6) · e1010928
DOI: 10.1371/journal.ppat.1010928 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 08.06.2023. Verfasst von Jinna Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Northeastern University, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Bacteriophages, Acinetobacter baumannii. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Northeastern University.
Abstract (Originalsprache)
Phage have gained renewed interest as an adjunctive treatment for life-threatening infections with the resistant nosocomial pathogen Acinetobacter baumannii . Our understanding of how A . baumannii defends against phage remains limited, although this information could lead to improved antimicrobial therapies. To address this problem, we identified genome-wide determinants of phage susceptibility in A . baumannii using Tn-seq. These studies focused on the lytic phage Loki, which targets Acinetobacter by unknown mechanisms. We identified 41 candidate loci that increase susceptibility to Loki when disrupted, and 10 that decrease susceptibility. Combined with spontaneous resistance mapping, our results support the model that Loki uses the K3 capsule as an essential receptor, and that capsule modulation provides A . baumannii with strategies to control vulnerability to phage. A key center of this control is transcriptional regulation of capsule synthesis and phage virulence by the global regulator BfmRS. Mutations hyperactivating BfmRS simultaneously increase capsule levels, Loki adsorption, Loki replication, and host killing, while BfmRS-inactivating mutations have the opposite effect, reducing capsule and blocking Loki infection. We identified novel BfmRS-activating mutations, including knockouts of a T2 RNase protein and the disulfide formation enzyme DsbA, that hypersensitize bacteria to phage challenge. We further found that mutation of a glycosyltransferase known to alter capsule structure and bacterial virulence can also cause complete phage resistance. Finally, additional factors including lipooligosaccharide and Lon protease act independently of capsule modulation to interfere with Loki infection. This work demonstrates that regulatory and structural modulation of capsule, known to alter A . baumannii virulence, is also a major determinant of susceptibility to phage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Northeastern University, Boston, Massachusetts, United States of America.
- Broad Institute of MIT and Harvard, CISID, Cambridge, Massachusetts, United States of America.
ORCID-Profile: Edward Geisinger
Förderung
- NIAID NIH HHS
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Northeastern University
Zitieren
APA
Bai, J., Raustad, N., Denoncourt, J., van Opijnen, T., & Geisinger, E. (2023). Genome-wide phage susceptibility analysis in Acinetobacter baumannii reveals capsule modulation strategies that determine phage infectivity. PLOS Pathogens, 19(6), e1010928. https://doi.org/10.1371/journal.ppat.1010928
Vancouver
Bai J, Raustad N, Denoncourt J, van Opijnen T, Geisinger E. Genome-wide phage susceptibility analysis in Acinetobacter baumannii reveals capsule modulation strategies that determine phage infectivity. PLOS Pathogens. 2023;19(6):e1010928. doi:10.1371/journal.ppat.1010928
BibTeX
@article{Bai2023,
author = {Bai, Jinna and Raustad, Nicole and Denoncourt, Jason and van Opijnen, Tim and Geisinger, Edward},
title = {Genome-wide phage susceptibility analysis in Acinetobacter baumannii reveals capsule modulation strategies that determine phage infectivity},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {6},
pages = {e1010928},
doi = {10.1371/journal.ppat.1010928}
}
EUVIMED